Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2021-12-17
2024-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of a Novel Nutritional Product on Nutrient Status and Digestive Health
NCT06181214
Bioavailability of Single-dose Magnesium Salts
NCT04139928
Beneficial Effects of Magnesium Supplementation On Idiopathic Muscle Cramps
NCT00963638
Effect of Magnesium Supplementation on Elevated Systolic Blood Pressure
NCT05690464
Magnesium and Vascular Stiffness
NCT03632590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ReMag
Liquid Lemon flavor drink containing 300 mg magnesium chloride (Regmag) consumed twice daily for 9 days
ReMag
300 mg of ReMag dissolved in lemon flavor liquid
ReMag Placebo
Liquid Lemon flavor drink placebo comparator consumed twice daily for 9 days.
Placebo
Lemon flavored liquid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ReMag
300 mg of ReMag dissolved in lemon flavor liquid
Placebo
Lemon flavored liquid
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult males and females (18 - 40 years, inclusive) who have exercised a minimum of 5 days per week, for a minimum of 30-minutes/session, during the previous 2 years.
* Maximal oxygen uptake (VO2max) satisfying the minimum criteria for "Good" (sex- and age-adjusted) as defined by the American College of Sports Medicine.
Exclusion Criteria
* Use of a magnesium supplement within the previous 4 weeks
* Pregnancy or breast-feeding
* Unable to perform vigorous exercise
* History (previous diagnosis) of kidney disease
* Use of laxatives, Zinc, diuretics, proton pump inhibitors, over the counter agents such as certain heartburn and GI/gut treatments (laxatives) which contain magnesium, Zinc or other high dose cations which reduce absorption of Magnesium
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Christopher Bell
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christopher Bell
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Colorado State University, Dept. of Health and Exercise Science
Fort Collins, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1659
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.